EDITORIAL ON MANAGEMENT OF DRUG TOXICITYWOOLLEY PV.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 11; PP. 1091; BIBL. 7 REF.Article

CLINICAL STUDIES. IV. CLINICAL PHARMACOLOGY AND PHASE I TRIAL DESIGNWOOLLEY PV; SCHEIN PS.1979; METHODS CANCER RES.; USA; DA. 1979; VOL. 17; PP. 177-198; BIBL. 2 P.Article

DOUBLE ANEUPLOIDY: PARTIAL TRISOMY 21 AND XO/XXX IN A FAMILY WITH 12/21 TRANSLOCATIONCHEN H; TYRKUS M; WOOLLEY PV et al.1978; ANN. GENET.; FRA; DA. 1978; VOL. 21; NO 3; PP. 177-180; ABS. FRE; BIBL. 17 REF.Article

CLINICAL STRATEGIES IN THE CHEMOTHERAPY OF GASTROINTESTINAL CANCERMACDONALD JS; WOOLLEY PV; SCHEIN PS et al.1980; RECENT RESULTS CANCER RES.; DEU; DA. 1980; VOL. 70; PP. 179-185; BIBL. 13 REF.Conference Paper

DELAYED RADIATION NECROSIS OF BRAINSTEM RELATED TO FAST NEUTRON BEAM IRRADIATION. CASE REPORT AND LITERATURE REVIEWMANZ HJ; WOOLLEY PV; ORNITZ RD et al.1979; CANCER; USA; DA. 1979; VOL. 44; NO 2; PP. 473-479; BIBL. 42 REF.Article

PHASE II STUDY OF PCNU IN COLORECTAL CARCINOMAWILLIS LL; SCHEIN PS; WOOLLEY PV et al.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 11-12; PP. 1129-1130; BIBL. 5 REF.Article

MODIFICATION OF L1210 CELL NUCLEAR PROTEINS BY 1-METHYL-1-NITROSOUREA AND 1-METHYL-3-NITRO-1-NITROSOGUANIDINEPINSKY SD; TEW KD; SMULSON ME et al.1979; CANCER RES.; USA; DA. 1979; VOL. 39; NO 3; PP. 923-928; BIBL. 30 REF.Article

NITROSOUREA INTERACTION WITH CHROMATIN AND EFFECT ON POLY(ADENOSINE DIPHOSPHATE RIBOSE) POLYMERASE ACTIVITYSUDHAKAR S; TEW KD; SCHEIN PS et al.1979; CANCER RES.; USA; DA. 1979; VOL. 39; NO 4; PP. 1411-1417; BIBL. 38 REF.Article

PHARMACOLOGIC DISPOSITION OF CHLOROZOTOCIN IN MICEMHATRE RM; PANASCI LC; FOX P et al.1978; CANCER TREATM. REP.; USA; DA. 1978; VOL. 62; NO 8; PP. 1145-1151; BIBL. 11 REF.Article

PHASE II TRIAL OF METHYL-G (METHYLGLYOXAL BIS-GUANYLHYDRAZONE) IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMAFUKS IZ; VAN ECHO DA; AISNER J et al.1981; CANCER CLIN. TRIALS; ISSN 0190-1206; USA; DA. 1981; VOL. 4; NO 4; PP. 411-414; BIBL. 14 REF.Article

CAMP (CYCLOPHOSPHAMIDE, DOXORUBICIN, METHOTREXATE, AND PROCARBAZINE) FOR EPIDERMOID AND LARGE CELL ANAPLASTIC CARCINOMA OF THE LUNGCAMBARERI RJ; SMITH FP; MACDONALD JS et al.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 3-4; PP. 317-320; BIBL. 15 REF.Article

5-FLUOROURACIL, ADRIAMYCIN, AND MITOMYCIN-C (FAM) CHEMOTHERAPY FOR ADVANCED ADENOCARCINOMA OF THE PANCREASSMITH FP; HOTH DF; LEVIN B et al.1980; CANCER; ISSN 0008-543X; USA; DA. 1980; VOL. 46; NO 9; PP. 2014-2018; BIBL. 14 REF.Article

PHASE II TRIAL OF STREPTOZOTOCIN, MITOMYCIN-C AND 5-FLUOROURACIL (SMF) IN THE TREATMENT OF ADVANCED PANCREATIC CANCER.WIGGANS RG; WOOLLEY PV III; MACDONALD JS et al.1978; CANCER; U.S.A.; DA. 1978; VOL. 41; NO 2; PP. 387-391; BIBL. 18 REF.Article

PHASE I TRIAL AND CLINICAL PHARMACOLOGY OF 1-(2-CHLOROETHYL)-3-(2,6-DIOXO-3-PIPERIDYL)- NITROUSERAWOOLLEY PV III; LUC PVT; AQUILUR RAHMAN et al.1981; CANCER RES.; ISSN 0008-5472; USA; DA. 1981; VOL. 41; NO 10; PP. 3896-3900; BIBL. 11 REF.Article

PHASE II STUDY OF CHLOROZOTOCIN IN LEUKEMIA AND OTHER HEMATOLOGIC MALIGNANCIESPAVLOVSKY S; WOOLLEY PV; GARAY G et al.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 11-12; PP. 1109-1111; BIBL. 6 REF.Article

A PHASE II STUDY OF CHLOROZOTORIN IN METASTATIC MALIGNANT MALENOMAHOTH DF; SCHEIN PS; WINOKUR S et al.1980; CANCER; ISSN 0008-543X; USA; DA. 1980; VOL. 46; NO 7; PP. 1544-1547; BIBL. 14 REF.Article

5-FLUOROURACIL, ADRIAMYCIN, AND MITOMYCIN-C (FAM) CHEMOTHERAPY FOR ADENOCARCINOMA OF THE LUGBUTLER TP; MACDONALD JS; SMITH FP et al.1979; CANCER; USA; DA. 1979; VOL. 43; NO 4; PP. 1183-1188; BIBL. 18 REF.Article

S-FLUOROURACIL (5-FU), METHYL-CCNU, AND VINCRISTINE IN THE TREATMENT OF ADVANCED COLORECTAL CANCER: PHASE II STUDY UTILIZING WEEKLY 5-FU.MACDONALD JS; KISNER DF; SMYTHE T et al.1976; CANCER TREATM. REP.; U.S.A.; DA. 1976; VOL. 60; NO 11; PP. 1597-1600; BIBL. 8 REF.Article

PROBABLE CLONAL ORIGIN OF ACUTE MYELOBLASTIC LEUKEMIA FOLLOWING RADIATION AND CHEMOTHERAPY OF COLON CANCERWIGGANS RG; JACOBSON RJ; FIALKOW PJ et al.1978; BLOOD; USA; DA. 1978; VOL. 52; NO 4; PP. 659-663; BIBL. 23 REF.Article

THERAPEUTIC USE OF TAMOXIFEN IN ADVANCED BREAST CANCER: CORRELATION WITH BIOCHEMICAL PARAMETERS.MORGAN LR JR; SCHEIN PS; WOOLLEY PV et al.1976; CANCER TREATM. REP.; U.S.A.; DA. 1976; VOL. 60; NO 10; PP. 1437-1443; BIBL. 14 REF.Article

PHASE II STUDIES OF METHYL GLYOXAL BIS-GUANYLHYDRAZONE (NSC 32946) IN CARCINOMA OF THE COLON AND LUNGKILLEN JY; MITCHELL EP; HOTH DF et al.1982; CANCER; ISSN 0008-543X; USA; DA. 1982; VOL. 50; NO 7; PP. 1258-1261; BIBL. 10 REF.Article

PHASE II TRIAL OF MITOXANTRONE IN ADVANCED COLORECTAL CANCERBONNEM EM; MITCHELL EP; WOOLLEY PV et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 11; PP. 1995-1996; BIBL. 6 REF.Article

PHASE II TRIAL OF 5-FLUOROURACIL, ADRIAMYCIN, AND MITOMYCIN C IN ADVANCED COLORECTAL CANCER.HALLER DG; WOOLLEY PV; MACDONALD JS et al.1978; CANCER TREATM. REP.; U.S.A.; DA. 1978; VOL. 62; NO 4; PP. 563-565; BIBL. 7 REF.Article

PHASE II TRIAL OF MITOGUAZONE IN PATIENTS WITH ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK = ESSAI PHASE II DE LA MITOGUAZONE CHEZ LES MALADES AYANT UN EPITHELIOMA EPIDERMOIDE AVANCE DE LA TETE ET DU COUPERRY DJ; CRAIN SM; WELTZ MD et al.1983; CANCER TREATMENT REPORTS; ISSN 0361-5960; USA; DA. 1983; VOL. 67; NO 1; PP. 91-92; ABS. ENG; BIBL. 5 REF.; GRAPHArticle

5-FLUOROURACIL, DOXORUBICIN, AND MITOMYCIN (FAM) COMBINATION CHEMOTHERAPY FOR ADVANCED GASTRIC CANCERMACDONALD JS; SCHEIN PS; WOOLLEY PV et al.1980; ANN. INTERN. MED.; ISSN 0003-4819; USA; DA. 1980; VOL. 93; NO 4; PP. 533-536; BIBL. 17 REF.Article